The primary purpose of this agreement is to produce pathogen-tested(clean) grapevine selections of interest to the eastern U.S. Viticulture communities and to extend information on the benefits of…

This cooperative agreement award from the US Department of Agriculture Animal and Plant Health Inspection Service provides $151,848 to Cornell University under the Plant and Animal Disease, Pest Control, and Animal Care federal grant program (CFDA 10.025) for the period of September 1, 2022 through August 31, 2023.

The primary purpose of the agreement is to produce pathogen-tested grapevine selections of interest to the eastern US viticulture communities and extend information on the benefits of clean planting material and the National Clean Plant Network (NCPN) to the grape and wine industries. Key deliverables include the introduction of 4-8 new grapevine selections, creation of 7 tissue culture selections for therapeutics, completion of therapeutics on 10 selections, completion of diagnostics on 13 fields, indexing of 3 selections, and partial or full curing of 9 selections. The work conducted under this agreement will primarily benefit the grape and wine industries in eastern states such as New York, Virginia, and Pennsylvania.

The primary purpose of this agreement is to produce pathogen-tested(clean) grapevine selections of interest to the eastern U.S. Viticulture communities and to extend information on the benefits of clean planting material and ncpn to the grape and wine industries. Our objectives are to (i) facilitate the safe introduction of high quality grape selections of interest to the eastern united states grape and wine industries through cornell's quarantine facilities, (II) test introduced grape material for viruses and other graft-transmissible agents, including agrobacterium vitis, (III) perform therapy procedures for pathogen elimination, (IV) release pathogen-tested (clean) selections to importers/introducers (v) extend information on the benefits of clean planting material and ncpn to the grape and wine industries. We anticipate the following deliverables: 1-introductions of four to eight new grapevine selections of interest to the eastern grape and wine industries from domestic and foreign sources 2-creation of seven tissue culture selections for therapeutics 3-completion of therapeutics on 10SELECTIONS 4- completion of thirteen field diagnostics 5-completion of indexing of three grapevine selections 6-complete or partial curing of nine grapevine selections. The grape and wine industries in the eastern U.S. (new york, virginia, pennsylvania, missouri, etc.,) will be primary benefit from our work.